BOOSTRIX
Biological
GlaxoSmithKline, LLC.
Total Payments
$2.1M
Transactions
3,591
Doctors
3,065
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $34.17 | 2 | 2 |
| 2023 | $2,192 | 55 | 46 |
| 2022 | $491.36 | 28 | 28 |
| 2021 | $2,571 | 172 | 161 |
| 2020 | $767,924 | 192 | 163 |
| 2019 | $1.1M | 281 | 251 |
| 2018 | $6,502 | 437 | 402 |
| 2017 | $252,679 | 2,424 | 2,110 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $2.0M | 59 | 96.7% |
| Food and Beverage | $53,482 | 3,516 | 2.5% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $6,362 | 8 | 0.3% |
| Consulting Fee | $5,125 | 5 | 0.2% |
| Travel and Lodging | $3,963 | 3 | 0.2% |
Payments by Type
Research
$2.0M
59 transactions
General
$68,931
3,532 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| RSV MAT-011 | GlaxoSmithKline, LLC. | $758,903 | 0 |
| A phase III, controlled, multicenter study to evaluate antibody persistence at 1, 3, 5 and 9 years following administration of a single dose of Tdap vaccine to healthy subjects, 19 years of age and older in the study 106316 Tdap 0.3 007 and to evaluate | GlaxoSmithKline, LLC. | $215,006 | 0 |
Top Doctors Receiving Payments for BOOSTRIX — Page 3
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , MD | Family Medicine | Surprise, AZ | $41.59 | 3 |
| , M.D | Family Medicine | Surprise, AZ | $41.59 | 3 |
| , MD | Internal Medicine | Fort Myers, FL | $41.42 | 2 |
| , MD | Internal Medicine | Mount Pleasant, PA | $41.11 | 2 |
| , MD | Family Medicine | Chesapeake, VA | $40.98 | 2 |
| , MD | Family Medicine | Chesapeake, VA | $40.98 | 2 |
| , MD | Family Medicine | Chesapeake, VA | $40.98 | 2 |
| , M.D | Family Medicine | Chesapeake, VA | $40.98 | 2 |
| , MD | Family Medicine | Chesapeake, VA | $40.98 | 2 |
| , MD | Internal Medicine | Mercerville, NJ | $40.61 | 2 |
| , MD | Internal Medicine | Hendersonville, TN | $40.35 | 2 |
| , MD | Family Medicine | Bowie, MD | $40.33 | 3 |
| , MD | Family Medicine | Chattanooga, TN | $40.01 | 2 |
| , M.D | Obstetrics & Gynecology | Saint Louis, MO | $39.80 | 2 |
| , M.D | Obstetrics & Gynecology | Saint Louis, MO | $39.80 | 2 |
| , M.D | Pulmonary Disease | Carmel, NY | $39.70 | 2 |
| , MD | Internal Medicine | Annapolis, MD | $39.52 | 2 |
| , MD | Internal Medicine | Annapolis, MD | $39.52 | 2 |
| , MD | Internal Medicine | Annapolis, MD | $39.52 | 2 |
| , MD | Obstetrics & Gynecology | Charleston, WV | $39.27 | 2 |
| , M.D | Obstetrics & Gynecology | Charleston, WV | $39.27 | 2 |
| , MD | Family Medicine | Orlando, FL | $38.92 | 2 |
| , DO | Neuromusculoskeletal Medicine & OMM | Chattanooga, TN | $38.84 | 2 |
| , MD | Family Medicine | Chattanooga, TN | $38.84 | 2 |
| , MD | Internal Medicine | Austin, TX | $38.63 | 3 |
Ad
Manufacturing Companies
- GlaxoSmithKline, LLC. $2.1M
Product Information
- Type Biological
- Total Payments $2.1M
- Total Doctors 3,065
- Transactions 3,591
About BOOSTRIX
BOOSTRIX is a biological associated with $2.1M in payments to 3,065 healthcare providers, recorded across 3,591 transactions in the CMS Open Payments database. The primary manufacturer is GlaxoSmithKline, LLC..
Payment data is available from 2017 to 2024. In 2024, $34.17 was paid across 2 transactions to 2 doctors.
The most common payment nature for BOOSTRIX is "Unspecified" ($2.0M, 96.7% of total).
BOOSTRIX is associated with 2 research studies, including "RSV MAT-011" ($758,903).